References
- AL Boner, D Bennati, C Castellani, L Sette, and M Schiasi. (1987). Bronchodilating activity of oral clenbuterol in asthmatic children after single administration of different dosages. Pediatr Pulmonol 3 (1):34–37.
- TT Laan, S Bull, RS Pirie, and J Fink-Gremmels. (2006). The anti-inflammatory effects of IV administered clenbuterol in horses with recurrent airway obstruction. Vet J 171 (3):429–437.
- G Mazzanti, C Daniele, G Boatto, G Manca, G Brambilla, and A Loizzo. (2003). New beta-adrenergic agonists used illicitly as growth promoters in animal breeding: chemical and pharmacodynamic studies. Toxicology 187 (2–3):91–99.
- V Dumustre-Toulet, V Cirimele, B Ludes, S Gromb, and P Kintz. (2002). Hair analysis of seven bodybuilders for anabolic steroids, ephedrine, and clenbuterol. J Forensic Sci 47 (1):211–214.
- Z Chodorowski, and J Sein Anand. (1997). Acute poisoning with clenbuterol – a case report. Przegl Lek 54 (10):763–764.
- AL Boner, G Vallone, C Brighenti, M Schiassi, P Miglioranzi, and C Richelli. (1988). Comparison of the protective effect and duration of action of orally administered clenbuterol and salbutamol on exercise-induced asthma in children. Pediatr Pulmonol 4 (4):197–200.
- AL Boner, L Sette, C Castellani, and M Schiassi. (1987). Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma. J Asthma 24 (6):347–353.
- K Torneke, C Ingvast-Larsson, and L Appelgren. (1997). Relaxation of equine tracheal muscle in vitro by different adrenoceptor drugs. J Vet Pharmacol Therap 20:216–219.
- J Barbosa, C Cruz, J Martins, JM Silva, C Neves, C Alves, F Ramos, and MI Da Silveira. (2005). Food poisoning by clenbuterol in Portugal. Food Addit Contam 22 (6):563–566.
- G Brambilla, T Cenci, F Franconi, R Galarini, A Macrì, F Rondoni, M Strozzi, and A Loizzo. (2000). Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol Lett 114 (1–3):47–53.
- L Salleras, A Dominguez, E Mata, JL Taberner, I Moro, and P Salva. (1995). Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep 110 (3):338–342.
- RS Hoffman, LS Nelson, GM Chan, SE Halcomb, NC Bouchard, BY Ginsburg, Y Jean-Francois, S Voit, S Marcus, M Ford, C Sanford, JE Michels, WH Richardson, LM Bretous, K Johnson-Arbor, J Thomas, C Barthold, M Belson, M Patel, J Schier, A Wolkin, C Rubin, and Z Duprey. (2005). Atypical reactions associated with heroin use – five states, January–April 2005. MMWR 54 (32):793–796.
- RJ Hoffman, RS Hoffman, CL Freyberg, RH Poppenga, and LS Nelson. (2001). Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. J Toxicol Clin Toxicol 39 (4):339–344.
- P Bilkoo, J Thomas, CD Riddle, and G Kagaoan. (2007). Clenbuterol toxicity: an emerging epidemic. A case report and review. Conn Med 71 (2):89–91.
- BA Smith. (1990). Strychnine poisoning. J Emerg Med 8 (3):321–325.
- AR Wijeskera, KD Henry, and P Ranasinghe. (1988). The detection and estimation of (A) arsenic in opium, and (B) strychnine in opium and heroin, as a means of identification of their respective sources. Forensic Sci Int 36 (3–4):193–209.
- M Kuno, and JN Weakly. (1972). Quantal components of the inhibitory synaptic potential in spinal mononeurones of the cat. J Physiol 224 (2):287–303.
- CE Cherubin. (1970). Epidemiology of tetanus in narcotic addicts. N Y State J Med 70 (2):267–71.
- Anonymous. (1998). Tetanus among injection drug users – California, 1997. MMWR 47 (8):149–151.
- M Ernst, ME Klepser, M Fouts, and MN Marangos. (1997). Tetanus: pathophysiology and management. Ann Pharmacother 31:1507–1513.
- DK Wright, UG Lalloo, S Nayiager, and P Govender. (1989). Autonomic nervous system dysfunction in severe tetanus: current perspectives. Crit Care Med 17:371–375.
- AG Wesley, and M Pather. (1987). Tetanus in children: an 11-year review. Ann Trop Paediatr 7 (1):32–37.
- JP Hellier, M Baudrimont, JC Dussaule, and F Berenbaum. (2002). Reversible selective β2-adrenoceptor agonist-induced myopathy. Rheumatology 41:111–113.
- B Tomlinson, and JM Cruickshanck. (1990). Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatinine changes in healthy subjects. Br J Clin Pharmacol 30:665–672.
- M Chiarotti, N Fucci, and C Furnari. (1991). Comparative analysis of illicit heroin samples. Forensic Sci Int 50 (1):47–56.
- N Fucci, and N De Giovanni. (1998). Adulterants encountered in the illicit cocaine market. Forensic Sci Int 95 (3):247–252.